Lantheus Holdings Inc (LNTH) - Total Liabilities
Based on the latest financial reports, Lantheus Holdings Inc (LNTH) has total liabilities worth $1.14 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Lantheus Holdings Inc (LNTH) long-term investment share to see how much of total assets are deployed in long-term investments.
Lantheus Holdings Inc - Total Liabilities Trend (2012–2025)
This chart illustrates how Lantheus Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Lantheus Holdings Inc total assets.
Lantheus Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Lantheus Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Rigetti Computing Inc
NASDAQ:RGTI
|
USA | $110.80 Million |
|
Arkema SA
PA:AKE
|
France | €7.88 Billion |
|
Fujian Wanchen Biotechnology Co. Ltd
SHE:300972
|
China | CN¥7.34 Billion |
|
OrangePL
WAR:OPL
|
Poland | zł13.79 Billion |
|
Bumrungrad Hospital PCL
BK:BH
|
Thailand | ฿6.06 Billion |
|
Vipshop Holdings Limited
NYSE:VIPS
|
USA | $35.12 Billion |
|
Ramelius Resources Ltd
AU:RMS
|
Australia | AU$483.64 Million |
|
Macy’s Inc
NYSE:M
|
USA | $11.38 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Lantheus Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See LNTH equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lantheus Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lantheus Holdings Inc (2012–2025)
The table below shows the annual total liabilities of Lantheus Holdings Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.14 Billion | +27.49% |
| 2024-12-31 | $892.33 Million | +6.83% |
| 2023-12-31 | $835.26 Million | -4.44% |
| 2022-12-31 | $874.11 Million | +118.89% |
| 2021-12-31 | $399.35 Million | +12.30% |
| 2020-12-31 | $355.62 Million | +22.07% |
| 2019-12-31 | $291.32 Million | -21.02% |
| 2018-12-31 | $368.83 Million | +2.29% |
| 2017-12-31 | $360.57 Million | -0.51% |
| 2016-12-31 | $362.41 Million | -15.26% |
| 2015-12-31 | $427.67 Million | -12.51% |
| 2014-12-31 | $488.84 Million | -1.61% |
| 2013-12-31 | $496.83 Million | -0.19% |
| 2012-12-31 | $497.76 Million | -- |
About Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceut… Read more